Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5%

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday.

The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma

The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma

Concert Pharmaceuticals Inc (NASDAQ:CNCE) has released highly positive Phase 3 data for their alopecia areata drug CTP-543 from the THRIVE-AA1 trial. Mizuho says that the efficacy supports its view that CTP-543 potentially has best-in-class efficacy amongst the three main oral JAK inhibitors in late-stage development for alopecia areata (CTP-543, Eli Lilly And Co's (NYSE: LLY)…

Raymond James View Skewed Scenarios On Absent Supportive Bid For This Animal Health Stock

Raymond James View Skewed Scenarios On Absent Supportive Bid For This Animal Health Stock

Raymond James downgraded the rating on Covetrus Inc (NASDAQ:CVET) from Outperform to Market Perform and removed the prior $22 price target after the company received a buyout at $21 per share. Though $21 may not ultimately prove to be the final resting place in terms of the offer price. Raymond James believes the proposed purchase…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Read Why Did HC Wainwright Cut Price Target On Atara Biotherapeutics

Late last week, Atara Biotherapeutics Inc (NASDAQ:ATRA) announced that Bayer AG (OTC:BAYRY) intends to terminate the exclusive worldwide licensing agreement for Atara's mesothelin-targeted allogeneic and autologous CAR-T assets, ATA3271 and ATA2271. The enrollment was paused in the Phase 1 trial of ATA2271 for mesothelioma after a patient death. The move followed a strategic review and asset-level prioritization.…

What 9 Analyst Ratings Have To Say About Array Technologies

Within the last quarter, Array Technologies (NASDAQ:ARRY) has observed the following analyst ratings:

This Investor Just Swapped Amazon Stock For Meta Platforms: Here's Why

One investor is shaking up her exposure to FAANG names after finding a valuation opportunity.

What 4 Analyst Ratings Have To Say About Vertex

Analysts have provided the following ratings for Vertex (NASDAQ:VERX) within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

American Airlines Group Whale Trades For May 23

American Airlines Group Whale Trades For May 23

A whale with a lot of money to spend has taken a noticeably bullish stance on American Airlines Group. Looking at options history for American Airlines Group (NASDAQ:AAL) we detected 12 strange trades.

Merger Arbitrage Mondays - U.S. Defense Contractor ManTech International To Be Acquired By Carlyle

Merger Arbitrage Mondays - U.S. Defense Contractor ManTech International To Be Acquired By Carlyle

Merger activity decreased last week with two new deals announced and three deals completed. ManTech International Corporation (NASDAQ: MANT)

Peering Into Bed Bath & Beyond's Recent Short Interest

Peering Into Bed Bath & Beyond's Recent Short Interest

Bed Bath & Beyond's (NASDAQ:BBBY) short percent of float has risen 20.96% since its last report. The company recently reported that it has 15.27 million shares sold short, which is 21.53% of all regular shares that are available for trading.

8 Analysts Have This to Say About Microsoft

8 Analysts Have This to Say About Microsoft

Analysts have provided the following ratings for Microsoft (NASDAQ:MSFT) within the last quarter:

Aggregate Insider Buying Remains Elevated For A Third Week $AMH

Aggregate Insider Buying Remains Elevated For A Third Week $AMH

In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across all three dimensions, number of unique insiders buying shares, the number of companies with insider buying…

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.

Toughbuilt Industries Clocks 40% Sales Growth In Q1

Toughbuilt Industries Clocks 40% Sales Growth In Q1

ToughBuilt Industries Inc (NASDAQ:TBLT) reported first-quarter FY22 revenue growth of 40% year-over-year to $17.2 million. Gross sales for Q1 through Amazon.Com, Inc (NASDAQ:AMZN) increased by 41% Y/Y to $3.4 million, compared to $2.4 million in 1Q21. Operating expenses were $18.4 million, compared to $9.4 million in 1Q21. Net loss attributable was $(12.1) million, or…

Get all your
news in one place.

100's of premium titles.
One news app.

Looking At Palo Alto Networks's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on Palo Alto Networks (NASDAQ:PANW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Inspired Entertainment Secures iGaming License In Pennsylvania

Inspired Entertainment Inc (NASDAQ:INSE) has secured an Interactive Gaming Manufacturer License in Pennsylvania as part of its North American expansion strategy. This license enables Inspired to offer its Interactive games to licensed online operators serving Pennsylvania. Inspired's Interactive content is expected to launch in the summer of 2022. "Pennsylvania is one of the…

Another Bear Week For Markets?

We are now down over 20% from the all-time high the S&P posted in January. That's after a week when traders tried to wrestle off a hungry bear, a week in which signs of an uptick proved unsustainable, a momentary lapse in the universe's judgment.

Here's How Much $100 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

Meta Platforms (NASDAQ:FB) has outperformed the market over the past 10 years by 9.67% on an annualized basis producing an average annual return of 21.17%. Currently, Meta Platforms has a market capitalization of $532.63 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

What's Going On With ImmunoGen Shares Today?

ImmunoGen, Inc. (NASDAQ: IMGN) shares are trading flat at $3.57 after the company's Biologics License Application to treat ovarian cancer was accepted by the FDA with priority review.

Sypris Bags Follow-On Multimillion-Dollar Contract From US Defense Contractor

Sypris Solutions Inc (NASDAQ:SYPR) subsidiary Sypris Electronics LLC has received a follow-on multimillion-dollar contract award from a U.S. global defense contractor for its electronic system modules. The terms of the agreement were not disclosed. Production is expected to begin in 2022. Sypris will manufacture advanced integrated electronic warfare and communications avionics system modules for…

Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday.

TPI Composites Names Ryan Miller As Finance Chief

TPI Composites Inc (NASDAQ:TPIC) has appointed Ryan Miller as Chief Financial Officer, effective May 23, 2022. Miller will lead TPI's finance, accounting, and investor relations functions. Miller has served in various financial and investor relations roles at Rockwell Collins and Collins Aerospace from December 2002 to February 2022. In December last year,…

30 Stocks Moving In Monday's Mid-Day Session

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Elbit Systems's Earnings: A Preview

Elbit Systems (NASDAQ:ESLT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Elbit Systems will report an earnings per share (EPS) of $1.89.

HC Wainwright & Co. Maintains Buy Rating for Atara Biotherapeutics: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Atara Biotherapeutics (NASDAQ:ATRA) and lower its price target from $31.00 to $29.00. Shares of Atara Biotherapeutics are trading down 3.1% over the last 24 hours, at $5.00 per share.

1 … 499 500 501 502

People

Bryn Talkington

Salvatore Calabrese

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

Palo Alto Networks

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Multiple Sclerosis

Places

387,695 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play